The Allen Institute for Immunology recently launched a retained search, led by The Chase Group, dedicated to building the computational biology team at the Institute…
Continue Reading →
A boutique firm working exclusively in life sciences, The Chase Group, with 25+ years’ executive search experience, can identify and deliver the highest quality executives…
Continue Reading →
Dr. Suzana Couto joins Genmab Pharmaceuticals as Head of Pathology, leading the pathology teams located in Utrecht, Netherlands, and Princeton, New Jersey. This international biotechnology…
Continue Reading →
The Chase Group is proud to be partnering with Genmab, a publicly traded, international, biotechnology company with the goal of transforming oncology research by discovering…
Continue Reading →
The Chase Group is pleased to announce the placement of the Vice President, Immuno-Oncology Global & US Medical Affairs for Eli Lilly. The successful candidate…
Continue Reading →
The Chase Group is pleased to announce our latest placement for Ionis Pharmaceuticals. Due to exciting organizational growth, Ionis welcomes a new Associate Director, Investor…
Continue Reading →
As Genmab continues its expansion into full product development, the need for high caliber talent is essential in executing their mission to create and develop…
Continue Reading →
The Chase Group is pleased to announce our recent partnership and executive search engagement with the highly-respected Allen Institute in Seattle, Washington. Devoted to unlocking…
Continue Reading →
The Chase Group is pleased to announce the successful completion of the Director, Clinical Research, Neuroscience at Eisai Inc. The successful candidate is a Board…
Continue Reading →
Genmab has once again retained The Chase Group with a new request to assist with the continued growth of their Translational Research team. The Chase…
Continue Reading →